A detailed history of Virginia Retirement Systems Et Al transactions in Alkermes Plc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 976,200 shares of ALKS stock, worth $28.9 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
976,200
Previous 569,800 71.32%
Holding current value
$28.9 Million
Previous $17.8 Million 53.32%
% of portfolio
0.27%
Previous 0.17%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 02, 2024

BUY
$27.17 - $31.97 $11 Million - $13 Million
406,400 Added 71.32%
976,200 $27.3 Million
Q2 2023

Aug 22, 2023

BUY
$28.34 - $33.63 $16.1 Million - $19.2 Million
569,800 New
569,800 $17.8 Million
Q4 2022

May 17, 2023

BUY
$21.94 - $26.24 $11.5 Million - $13.8 Million
525,200 Added 954.91%
580,200 $15.2 Billion
Q3 2022

May 16, 2023

BUY
$22.0 - $31.87 $415,800 - $602,343
18,900 Added 52.35%
55,000 $1.23 Billion
Q1 2022

Apr 21, 2022

SELL
$23.07 - $27.99 $440,637 - $534,609
-19,100 Reduced 34.6%
36,100 $950,000
Q4 2021

Feb 03, 2022

SELL
$21.47 - $32.08 $1.1 Million - $1.65 Million
-51,300 Reduced 48.17%
55,200 $1.28 Million
Q3 2021

Oct 21, 2021

SELL
$23.37 - $32.13 $271,092 - $372,708
-11,600 Reduced 9.82%
106,500 $3.28 Million
Q2 2021

Aug 13, 2021

SELL
$18.78 - $25.15 $407,526 - $545,755
-21,700 Reduced 15.52%
118,100 $2.9 Million
Q1 2021

Apr 30, 2021

BUY
$18.21 - $23.2 $1.33 Million - $1.69 Million
72,900 Added 108.97%
139,800 $2.61 Million
Q4 2020

Feb 16, 2021

BUY
$15.39 - $22.1 $526,338 - $755,820
34,200 Added 104.59%
66,900 $1.34 Million
Q3 2020

Nov 12, 2020

BUY
$16.16 - $20.66 $528,432 - $675,582
32,700 New
32,700 $542,000
Q1 2020

May 12, 2020

SELL
$13.06 - $21.24 $1.84 Million - $2.99 Million
-140,800 Closed
0 $0
Q4 2019

Jan 27, 2020

BUY
$17.29 - $21.74 $2.43 Million - $3.06 Million
140,800 New
140,800 $2.87 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.87B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.